kabutan

TEIJIN LIMITED(3401) Summary

3401
TSE Prime
TEIJIN LIMITED
1,570.0
JPY
+8.0
(+0.51%)
Apr 28, 3:30 pm JST
9.86
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
PBR
0.78
Yield
3.18%
Margin Trading Ratio
8.54
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,560.0 JPY 9.78 USD
Previous Close Apr 27
1,562.0 JPY 9.79 USD
High Apr 28, 9:17 am
1,571.5 JPY 9.86 USD
Low Apr 28, 9:02 am
1,555.5 JPY 9.76 USD
Volume
561,400
Trading Value
0.88B JPY 5.52M USD
VWAP
1566.36 JPY 9.84 USD
Minimum Trading Value
157,000 JPY 986 USD
Market Cap
0.31T JPY 1.95B USD
Number of Trades
1,416
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
2,058
1-Year High Apr 14, 2026
12,637
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 126,500 223,500 1.77
Apr 17, 2026 159,500 198,500 1.24
Apr 10, 2026 182,200 2,158,100 11.84
Apr 3, 2026 193,700 2,163,600 11.17
Mar 27, 2026 193,300 2,175,700 11.26
Company Profile
TEIJIN LIMITED is a major synthetic fiber manufacturer, ranking second globally in carbon fiber production. The company's three main pillars are synthetic fibers, chemical products, and pharmaceuticals/medical care. It also has a presence in the healthcare sector.
Sector
Texstiles & Apparels
TEIJIN LIMITED operates in various business segments including materials, fibers & products, healthcare, and IT. In its materials business, the company manufactures and sells high-performance materials such as aramid fibers, resins, and carbon fibers, as well as composite materials. The fibers & products division focuses on the manufacture and sale of fiber products, polyester fibers, and textiles. In healthcare, TEIJIN LIMITED manufactures and sells pharmaceuticals and medical devices, while also providing home healthcare services. The IT business segment offers information system operation, development, and maintenance services, as well as electronic comic distribution. Additionally, the company manufactures and sells battery materials and membranes, and develops, manufactures, and sells regenerative medicine products and implantable medical devices.